NET PROFIT (x1000 NOK)
EMPLOYEES
Fisher Scientific Biotech Line A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 0 | 0 | 0 |
Earnings before taxes | 15,432 | 177,148 | -9,201 |
Total assets | 18,686,336 | 11,198,123 | 10,757,036 |
Current assets | 57,857 | 49,462 | 193,924 |
Current liabilities | 115,899 | 98,595 | 691,605 |
Equity capital | 18,570,437 | 11,099,528 | 10,065,431 |
- share capital | 757 | 711 | 673 |
Employees (average) | 15 | 15 | 15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 99.4% | 99.1% | 93.6% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio | 49.9% | 50.2% | 28.0% |
Return on equity (ROE) | 0.1% | 1.6% | -0.1% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.